精神活性物质依赖患者共病研究。
A study of comorbidity in psychoactive substance dependence patients.
机构信息
Pankaj Kishore, MD, Ex-Resident and Research Officer, Department of Psychiatry, K.G's Medical College, Lucknow, Uttar Pradesh - 226 003.
出版信息
Indian J Psychiatry. 1994 Jul;36(3):133-7.
Abstract
The study assessed the lifetime prevalence of comorbidity in forty three DSM III-R opioid and alcohol dependent patients. A total lifetime prevalence rate of 60.5% was found. The results are discussed axis wise and compared with previous relevant studies. There was no significant difference in comorbidity between the opioid and alcohol Dependent groups. Comorbidity on both Axis I and II were high, but there was no significant difference in the presence of Axis I disorders between patients with and without personality disorders. The paper also reports upon the temporal relationships amongst the co-occurring psychiatric disorders.
摘要
本研究评估了 43 名 DSM-III-R 阿片类药物和酒精依赖患者一生中共病的患病率。发现总终生患病率为 60.5%。结果按轴进行讨论，并与以前的相关研究进行了比较。阿片类药物和酒精依赖组之间的共病没有显著差异。轴 I 和 II 上的共病都很高，但在是否存在人格障碍方面，患有和不患有轴 I 障碍的患者之间没有显著差异。本文还报告了同时发生的精神障碍之间的时间关系。
相似文献
1
A study of comorbidity in psychoactive substance dependence patients.精神活性物质依赖患者共病研究。
Indian J Psychiatry. 1994 Jul;36(3):133-7.
2
[Cannabis and schizophrenia: demographic and clinical correlates].[大麻与精神分裂症：人口统计学及临床相关性]
Encephale. 2003 Jan-Feb;29(1):11-7.
3
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.全国共病调查中 DSM-III-R 酒精滥用和依赖与其他精神障碍的终生共病情况。
Arch Gen Psychiatry. 1997 Apr;54(4):313-21. doi: 10.1001/archpsyc.1997.01830160031005.
4
Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.美国《精神疾病诊断与统计手册》第四版（DSM-IV）药物滥用和依赖的患病率、相关因素、残疾情况及共病现象：酒精及相关疾病全国流行病学调查结果
Arch Gen Psychiatry. 2007 May;64(5):566-76. doi: 10.1001/archpsyc.64.5.566.
5
Psychiatric and Substance Use Comorbidity in Treatment-Seeking Injection Opioid Users Referred From Syringe Exchange.来自针头交换项目的寻求治疗的注射用阿片类药物使用者的精神疾病与物质使用共病情况
J Dual Diagn. 2018 Oct-Dec;14(4):193-200. doi: 10.1080/15504263.2018.1510148. Epub 2018 Oct 17.
6
Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China.中国长沙海洛因依赖者的精神障碍概况。
Drug Alcohol Depend. 2015 Apr 1;149:272-9. doi: 10.1016/j.drugalcdep.2015.01.028. Epub 2015 Feb 2.
7
Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.因人格障碍接受治疗的患者中物质使用障碍的轴II共病情况。
Am J Psychiatry. 1999 May;156(5):733-8. doi: 10.1176/ajp.156.5.733.
8
Psychiatric comorbidity among patients on methadone maintenance therapy and its influence on quality of life.美沙酮维持治疗患者的精神疾病共病及其对生活质量的影响。
Am J Addict. 2016 Jan;25(1):49-55. doi: 10.1111/ajad.12317. Epub 2015 Dec 21.
9
Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.美国《精神疾病诊断与统计手册》第四版中酒精滥用与酒精依赖的患病率、相关因素、残疾情况及共病情况：酒精及相关疾病全国流行病学调查结果
Arch Gen Psychiatry. 2007 Jul;64(7):830-42. doi: 10.1001/archpsyc.64.7.830.
10
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.美国精神疾病诊断与统计手册第三版修订版（DSM-III-R）精神障碍的终生患病率和12个月患病率。来自国家共病调查的结果。
Arch Gen Psychiatry. 1994 Jan;51(1):8-19. doi: 10.1001/archpsyc.1994.03950010008002.
引用本文的文献
1
Electroencephalography-based cortical sources of working memory in the subjects with opioid addiction: A pilot study.基于脑电图的阿片类药物成瘾者工作记忆的皮质源：一项初步研究。
Indian J Med Res. 2021 Apr;154(4):583-591. doi: 10.4103/ijmr.IJMR_941_20.
2
A Cross-sectional Study of Psychiatric Comorbidity and Severity of Addiction in Patients with Early- and Late-Onset Alcohol Dependence.早发性和迟发性酒精依赖患者精神共病与成瘾严重程度的横断面研究
Indian J Psychol Med. 2020 Jul 18;42(4):334-340. doi: 10.1177/0253717620928443. eCollection 2020 Jul.
3
Age of onset of substance use in patients with dual diagnosis and its association with clinical characteristics, risk behaviors, course, and outcome: A retrospective study.双重诊断患者物质使用的起始年龄及其与临床特征、风险行为、病程和结局的关联：一项回顾性研究。
Indian J Psychiatry. 2019;61(4):359-368. doi: 10.4103/psychiatry.IndianJPsychiatry_454_18.
4
Guidelines for psychosocial interventions in addictive disorders in India: An introduction and overview.印度成瘾性疾病心理社会干预指南：引言与概述
Indian J Psychiatry. 2018 Feb;60(Suppl 4):S433-S439. doi: 10.4103/psychiatry.IndianJPsychiatry_35_18.
5
A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders.印度共病大麻使用障碍和精神障碍研究述评。
Indian J Med Res. 2017 Aug;146(2):186-195. doi: 10.4103/ijmr.IJMR_791_15.
6
Psychiatric Comorbidity and Physical Correlates in Alcohol-dependent Patients.酒精依赖患者的精神共病与身体相关因素
Indian J Psychol Med. 2016 Sep-Oct;38(5):414-418. doi: 10.4103/0253-7176.191397.
7
A Review of Indian Research on Co-occurring Psychiatric Disorders and Alcohol use Disorders.印度关于共病精神障碍和酒精使用障碍的研究综述
Indian J Psychol Med. 2016 Jan-Feb;38(1):10-9. doi: 10.4103/0253-7176.175089.
8
A descriptive analysis of patients presenting to psychosexual clinic at a tertiary care center.对一家三级护理中心性心理诊所的就诊患者进行的描述性分析。
Indian J Psychol Med. 2013 Jul;35(3):241-7. doi: 10.4103/0253-7176.119473.
9
An overview of Indian research in personality disorders.印度人格障碍研究概述。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S250-4. doi: 10.4103/0019-5545.69241.
10
Indian research on comorbidities.印度对合并症的研究。
Indian J Psychiatry. 2010 Jan;52(Suppl 1):S246-9. doi: 10.4103/0019-5545.69240.
本文引用的文献
1
Prevalence and psychiatric heterogeneity of alcoholism in a United States urban community.美国城市社区中酒精中毒的患病率及精神疾病异质性
J Stud Alcohol. 1980 Jul;41(7):672-81. doi: 10.15288/jsa.1980.41.672.
2
Heterogeneity of psychiatric diagnosis in treated opiate addicts.接受治疗的阿片类药物成瘾者的精神疾病诊断异质性。
Arch Gen Psychiatry. 1982 Feb;39(2):161-8. doi: 10.1001/archpsyc.1982.04290020027006.
3
Panic disorder and major depression. Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder.惊恐障碍与重度抑郁症。患有惊恐障碍的抑郁症先证者家族中，患抑郁症、酒精中毒、惊恐障碍和恐惧症的风险增加。
Arch Gen Psychiatry. 1983 Oct;40(10):1055-60. doi: 10.1001/archpsyc.1983.01790090017002.
4
Drug use in health and mental illness in an Indian population.
Br J Psychiatry. 1971 Mar;118(544):345-6. doi: 10.1192/bjp.118.544.345.
5
Co-morbidity and depression among the anxiety disorders. Issues in diagnosis and classification.焦虑症中的共病与抑郁。诊断与分类问题。
J Nerv Ment Dis. 1986 Feb;174(2):63-72. doi: 10.1097/00005053-198602000-00001.
6
Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults.关于年轻人精神障碍早发及药物滥用风险较高的流行病学证据。
Am J Psychiatry. 1988 Aug;145(8):971-5. doi: 10.1176/ajp.145.8.971.
7
The prevalence of psychiatric disorders in patients with alcohol and other drug problems.患有酒精及其他药物问题的患者中精神障碍的患病率。
Arch Gen Psychiatry. 1988 Nov;45(11):1023-31. doi: 10.1001/archpsyc.1988.01800350057008.
8
Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships.
Am J Psychiatry. 1990 Aug;147(8):1025-8. doi: 10.1176/ajp.147.8.1025.
9
10
Comorbidity: a central concern of psychiatry in the 1990s.
Hosp Community Psychiatry. 1991 Apr;42(4):345. doi: 10.1176/ps.42.4.345.
Zotero 插件